Tower Research Capital (TRC)’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-22,443
| Closed | -$4.38K | – | 6273 |
|
2023
Q4 | $4.38K | Sell |
22,443
-425
| -2% | -$83 | ﹤0.01% | 4962 |
|
2023
Q3 | $8.37K | Buy |
22,868
+18,069
| +377% | +$6.61K | ﹤0.01% | 4356 |
|
2023
Q2 | $5.18K | Sell |
4,799
-4,347
| -48% | -$4.7K | ﹤0.01% | 4827 |
|
2023
Q1 | $6K | Buy |
9,146
+2,636
| +40% | +$1.73K | ﹤0.01% | 4912 |
|
2022
Q4 | $7K | Sell |
6,510
-381
| -6% | -$410 | ﹤0.01% | 4651 |
|
2022
Q3 | $12K | Sell |
6,891
-7,736
| -53% | -$13.5K | ﹤0.01% | 4396 |
|
2022
Q2 | $23K | Buy |
14,627
+14,440
| +7,722% | +$22.7K | ﹤0.01% | 3674 |
|
2022
Q1 | $0 | Sell |
187
-3,726
| -95% | – | ﹤0.01% | 6753 |
|
2021
Q4 | $18K | Buy |
3,913
+2,861
| +272% | +$13.2K | ﹤0.01% | 3816 |
|
2021
Q3 | $10K | Buy |
+1,052
| New | +$10K | ﹤0.01% | 4360 |
|